Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Negma Group is a diversified investment fund specializing in debt and equity financing, venture capital funding, and quantitative trading strategies. It supports entrepreneurs and investors by creating long-term value through innovative growth strategies. Founded in 2013, the firm has deployed over $1 billion in capital commitments and financed around 60 companies across multiple industries including health/life sciences[4]. It has recently provided significant financing to clinical-stage biotech firms such as Evaxion Biotech[5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Negma Group.